Metraipolis › archive › dc_d38eaeeb04c2

The Current and Future Role of MRI and PSMA-PET/CT in Diagnosing Oligometastatic Prostate Cancer — Europe PMC PMID:41358937

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41358937
DOI: 10.1097/rli.0000000000001264
License (as archived): solo-consultazione
Archived: 2026-11-05T11:20:43.439Z
SHA-256 of the archived text: 6ba4aeadaf407c77c51f271e90460e8c3f663686ed73a052c09596d4c53628b2
Stable URL of this page: https://metraipolis.com/documento/dc_d38eaeeb04c2

How to cite

The Current and Future Role of MRI and PSMA-PET/CT in Diagnosing Oligometastatic Prostate Cancer — Europe PMC PMID:41358937 — Europe PMC (en), https://europepmc.org/article/MED/41358937 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d38eaeeb04c2 (Metraipolis archive dc_d38eaeeb04c2, sha256 6ba4aeadaf407c77c51f271e90460e8c3f663686ed73a052c09596d4c53628b2)

BibTeX

@misc{dcd38eaeeb04c2,
  title = {The Current and Future Role of MRI and PSMA-PET/CT in Diagnosing Oligometastatic Prostate Cancer — Europe PMC PMID:41358937},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41358937},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d38eaeeb04c2; sha256 6ba4aeadaf407c77c51f271e90460e8c3f663686ed73a052c09596d4c53628b2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41358937. Agents can read the archived copy with the MCP tool read_document.